Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000473620 | SCV000551227 | uncertain significance | Hereditary nonpolyposis colon cancer | 2018-08-01 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine with tyrosine at codon 1327 of the MSH6 protein (p.Asn1327Tyr). The asparagine residue is weakly conserved and there is a large physicochemical difference between asparagine and tyrosine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with a MSH6-related disease. ClinVar contains an entry for this variant (Variation ID: 410496). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, this variant has uncertain impact on MSH6 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000571258 | SCV000669948 | uncertain significance | Hereditary cancer-predisposing syndrome | 2016-12-28 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Insufficient evidence |